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ABSTRACT 
INTRODUCTION: Urbanization of Trypanosoma cruzi and Leishmania 
infantum have increased in Latin America. This has result in an increased risk 
of infections to a large population.  There is mandatory blood screening for T. 
cruzi infection, but there is none for L. infantum. 
MANUSCRIPT 1: Evaluation of Leishmania infantum infection in humans 
using commercial Trypanosoma cruzi assay: the importance of assessing 
cross-reaction  
BACKGROUND: L. infantum and T. cruzi share many common epitopes, with 
cross-reaction between serological assays.   
OBJECTIVES: To evaluate the sensitivity of a commercial T. cruzi ELISA 
assay for diagnosing L. infantum infection. 
METHODS: A total of 573 subjects from an endemic area of visceral 
leishmaniasis in Brazil were studied. Of those, 350 were symptomatic visceral 
leishmania patients (Symp VL); 87 were recovered VL individuals (Rec VL), 
and 96 were healthy household contacts of a VL case (HHC).  Leishmania 
infection was estimated by a commercial T. cruzi (CHAGAS III) assay and 
soluble Leishmania antigens (SLA) ELISA, PCR and skin delayed type 
hypersensitivity responses (DTH).  
RESULTS:  The sensitivity of the T. cruzi assay to ascertain Symp VL was 
76% and its specificity was 91.7%. There was a positive correlation of both the 
T. cruzi and SLA ELISA assays with the level of anti-Leishmania antibodies 
(r=0.487, p<0.0001). The response was higher for Symp VL in both the T. 
cruzi (OR 39.1; p<0.0001) and the SLA (OR=41.5; p<0.0001)  relative to HHC 
assays. There was an inverse relationship between presence of antibodies 
and  DTH response: 88.2% of people who were DTH positive were T. cruzi 
negative and 53.9% who were DTH negative were T. cruzi positive 
(p<0.0001).  
CONCLUSIONS:  The commercial T. cruzi assay (CHAGAS III) is sensitive for 
detecting L. infantum infection. The positivity of the test correlated with the 
level of anti-Leishmania antibodies. 
MANUSCRIPT 2: SEROLOGICAL SURVEY OF LEISHMANIA INFECTION IN 
BLOOD DONORS FROM AN ENDEMIC AREA OF VISCERAL 
LEISHMANIASIS IN BRAZIL 
BACKGROUND. Asymptomatic Leishmania infection has increased in urban 
areas of Brazil, which could pose a risk of Leishmania transmission through 
blood transfusion or organ transplantation. 
OBJECTIVES: To determine the prevalence of Leishmania infantum infections 
in blood donors of an endemic area for visceral leishmaniasis in Brazil. 
METHODS. A cross-sectional study was performed, with weekly recruitment of 
volunteers from February 2014 to January 2015. A total of 1556 participants 
who were donating blood in Natal, Brazil were recruited. Participants 
answered a questionnaire related to exposure to Leishmania. Results of their 
blood screening were analyzed.  Blood samples were tested for Leishmania 
infection using a soluble Leishmania antigens (SLA) ELISA assay. Likelihood 
Ratio Chi-Square test evaluated the association between categorical 
variables. Simple and multiple regression models evaluated the effect of 
covariates and factors on Leishmania response. The results of the SLA ELISA 
were log transformed and ratio obtained, considering the cutoff value for each 
plate.  
RESULTS: A total of 51,463 people donated blood to public blood banks in 
2014 and of those, 1554 (3%) were recruited. The majority of donors were 
males (82.4%) and married (51.8%). The literacy rate was high with 68% of 
the participants having completed high school. The mean body mass index for 
males and females were, respectively, 27.96 and 27.99 kg/m2. The 
seroprevalence of T. cruzi and Leishmania were 0.19% and 2.5%. Leishmania 
was isolated from one of the samples cultured (600). 
CONCLUSIONS. There is risk of Leishmania transmission through the blood 
supply. Close monitoring of blood recipients is warranted, principally in those 
with some type of immunosuppression. T. cruzi ELISA assay can identify a 
subgroup of L. infantum contaminated blood, but does not exclude all positive 
samples. 
 
  
 
iii
BIOGRAPHICAL SKETCH 
Selma M.B. Jeronimo received a Bachelor in Biology from the Federal 
University of Rio Grande do Norte, in Natal, Brazil; she also earned her Doctor 
of Medicine from the same institution. She is currently a Professor of 
Biochemistry and the Director of the Institute of Tropical Medicine, from the 
Federal University of Rio Grande do Norte. She is interested in improving 
strategies for treatment and eventual control of neglected tropical diseases in 
her home state. The implementation of the Institute of Tropical Medicine is one 
of the means to reach these goals.   
  
 
iv
 
 
 
 
 
 
 
 
 
 
Dedicated to my beloved mother, Dulcimar Bezerra de Medeiros, in memorian 
  
 
v
ACKNOWLEDGMENTS 
Warren D. Johnson 
Marshall Glesby 
Mary Charlson 
Carol Mancuso 
Jim Hollenberg 
Cyre Guadalupe 
Kathryn Dupnik 
Lyndsey Reif 
Shannel Grant 
Herda Michel 
Edgar M. Carvalho 
Erika V. M. Dias Paiva 
Erinaldo Vitor 
Linete Rocha 
Manoel Josué Batista-Neto 
Cleber Mesquita 
Mary E. Wilson 
Richard D. Pearson 
Glória R. Monteiro 
Francisco Freire Neto 
Iraci Lima 
Joanna G. Valverde 
José Flávio Coutinho 
Jose Wilton Queiroz 
Joyce Rocha 
  
 
vi
Marcelo Melo 
Marcos Oliveira-Filho 
Margarita Mavromatis 
Paulo R. Nascimento 
Washington Araujo 
  
  
 
vii
TABLE OF CONTENTS 
BIOGRAPHICAL SKETCH   III 
DEDICATION PAGE   IV 
ACKNOWLEDGEMENTS   V 
CHAPTER 1: Evaluation of Leishmania infantum infection in humans 
using commercial Trypanosoma cruzi assay: the importance of 
assessing cross-reaction  
1 
 TITLE PAGE 2 
 CONFLICT OF INTEREST NOTIFICATION PAGE 3 
 ABSTRACT 4 
 MANUSCRIPT TEXT  
  INTRODUCTION   6 
  METHODS    9 
  RESULTS   10 
  DISCUSSION   16 
 REFERENCES   20 
 
      
  
 
viii
LIST OF FIGURES 
Figure 1.   Results of the log of the (SLA ELISA/Cutoff) (X 
axis) versus the log of the (T. cruzi/Cutoff) assay 
(Y axis).  
13 
 
  
  
 
ix
LIST OF TABLES 
 
Table 1. Sex and age distribution of the study 
population by group 
11 
Table 2. Results of the T. cruzi assay among people 
exposed to L. infantum with distinct clinical 
outcomes 
11 
Table 3. Cross tabulation of the results of the T. cruzi 
and the SLA ELISA assays 
12 
Table 4. Results of  serological assays for T. cruzi and 
L. infantum by sex 
14 
Table 5. Regression model considering the results of 
the two serological tests (SLA and T. cruzi) and 
groups. 
14 
Table 6 Parameter estimates of logistical models with 
the serological assay results as response and 
group status and age as predictors. 
15 
Table 7 Distribution of DTH response among groups. 15 
Table 8. Quantification of Leishmania DNA in  the 
blood. 
16 
 
 
 
  
 
x
 
 
CHAPTER 2:  Serological survey of Leishmania infection in blood 
donors from an endemic area of visceral leishmaniasis in Brazil 
25 
 TITLE PAGE 26 
 CONFLICT OF INTEREST NOTIFICATION PAGE 27 
 ABSTRACT 28 
 MANUSCRIPT TEXT  
  INTRODUCTION   30 
  METHODS    32 
  RESULTS   36 
  DISCUSSION   44 
 REFERENCES   48 
 
 
  
 
xi
LIST OF FIGURES 
 
Figure 1.  Distribution of the body mass index by category 
(A) and age group (B) 
37 
Figure 2. Quantitative results of the SLA ELISA, stratified 
by positive positive and negative values. 
39 
Figure 3. Frequency Distribution of LogSLARatio 40 
Figure 4. Rainfall per quarter for the state of Rio Grande 
between January 2012 to February 2015 (A) and 
the Log of the SLA/Ratio, between December 
2013 to January 2015, with 95% confidence 
interval (B). 
41 
Figure 5. Temporal variation in rainfall from January 2012 
to February 2015 and the LogSLARatio from 
December 2013  to January 2015. 
42 
 
  
  
 
xii
 
LIST OF TABLES 
Table 1. Statistics for BMI by age groups. 36 
Table 2. Results of the blood screening. The ratio infection rate 
is presented per 10,000 with the 95% confidence 
interval.  
38 
Table 3. Results of the anti-leishmania antibodies in blood 
donors. 
39 
Table 4. Cross tabulation of SLA ELISA with T. cruzi ELISA 40 
Table 5. Parameter estimates of Leishmania infection along the 
year, using a linear model  considering the Log SLA 
ratio as the Dependent Variable 
41 
Table 6. Logistic Regression Models of Potential risk factors for 
leishmania infection 
43 
 
 
 
  
  
 
1
 
 
 
 
 
 
CHAPTER 1 
 
Evaluation of Leishmania infantum infection in humans using commercial 
Trypanosoma cruzi assay: the importance of assessing cross-reaction  
 
 
 
 
  
  
 
2
TITLE PAGE 
 
Evaluation of Leishmania infantum infection in humans using commercial 
Trypanosoma cruzi assay: the importance of assessing cross-reaction  
Selma M.B. Jeronimo,1,2,3 José Wilton Queiroz,2 Marshall J. Glesby4 and 
Warren D. Johnson5 
1) Department of Biochemistry, Bioscience Center, Federal University of 
Rio Grande do Norte 
2) Institute of Tropical Medicine of Rio Grande do Norte, Federal 
University of Rio Grande do Norte 
3) Institute of Science and Technology of Tropical Diseases, INCT-DT 
4) Division of Infectious Diseases, Weill Cornell Medical College 
5) Center for Global Health, Weill Cornell Medical College 
 
Contact Information: 
Selma M.B. Jeronimo 
Institute of Tropical Medicine of Rio Grande do Norte 
Campus Universitário 
Natal, RN, Brazil 
Phone: 55-84-3342-2286 
Supported by the National Institutes of Health [Tropical Medicine Research 
Center  AI 030639, Forgarty International Center (U2RTW006885),  and 
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) 
Word Count: 3209 
  
  
 
3
 
CONFLICT OF INTEREST NOTIFICATION PAGE 
There are no conflicts of interest to report. 
 
  
 
4
ABSTRACT 
MANUSCRIPT 1: Evaluation of Leishmania infantum infection in humans 
using commercial Trypanosoma cruzi assay: the importance of assessing 
cross-reaction  
BACKGROUND: Asymptomatic L. infantum infection has increased in urban 
areas of Brazil and there could be a risk of its transmission through the blood 
supply. We hypothesized T. cruzi screening would identify a subset of the 
Leishmania positive samples because of cross reactivity. 
OBJECTIVES: To evaluate the sensitivity of a commercial T. cruzi ELISA 
assay for diagnosing L. infantum infection. 
METHODS: A total of 573 subjects residing in the state of Rio Grande do 
Norte, Northeast Brazil were studied. Of those, 350 were symptomatic visceral 
leishmaniasis patients (Symp VL); 87 were recovered VL (Rec VL), and 96 
were healthy household contacts of a VL case (HHC).  We reviewed their 
clinical status and analyzed their blood for Leishmania infection by using both 
a commercial T. cruzi (CHAGAS III) assay and soluble Leishmania antigens 
(SLA) ELISA assays. Quantitative PCR was used to estimate the load of 
Leishmania in the blood. Rec VL and HHC subjects were tested for their skin 
delayed type hypersensitivity responses (DTH). The McNemar´s test assessed 
the null hypothesis that there was no association between the assays. The 
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sensitivity and specificity of the T. cruzi assay in identifying Leishmania 
infection were determined.  
RESULTS:  Of the Symp VL, 98.6%(345) were positive by SLA ELISA and 
76.0% (266) were positive by the T. cruzi assay; whereas for the Rec VL, the 
positivity of the SLA and T. cruzi assays were, respectively, 81.6% (71) and 
16.1% (14), and for the HHC, they were, respectively, 60.4% (58) and 8.3% 
(8). In all three groups, a significant association between the results of the T. 
cruzi and SLA assays was observed. The sensitivity of the T. cruzi assay to 
ascertain Symp VL was 76% and its specificity was 91.7%.There was a 
positive correlation of both the T. cruzi and SLA ELISA assays with the level of 
anti-Leishmania antibodies (r=0.487, p<0.0001). The response was higher for 
Symp VL in both the T. cruzi (OR39.1; p<0.0001) and the SLA (OR=41.5; 
p<0.0001) assays relative to HHC assays. There was an inverse relationship 
between presence of antibodies and  DTH response: 88.2% of people who 
were DTH positive were T. cruzi negative and 53.9% who were DTH negative 
were T. cruzi positive (p<0.0001). 
CONCLUSIONS:  The commercial T. cruzi assay (CHAGAS III) is sensitive for 
detecting a L. infantum infection. The positivity of the test correlated with the 
level of anti-Leishmania antibodies. These findings indicate the need for better 
assays to rule out dual infection and to ascertain the correct diagnosis of either 
L. infantum or T. cruzi infections. 
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INTRODUCTION 
Visceral Leishmaniasis (VL) is a vector-borne illness that in Latin 
America and Europe is an anthropozoonosis, commonly caused by 
Leishmania infantum, a Trypanosomatidae.(Deane, 1958; Mott et al., 1990) In 
Latin America, this pathogen is transmitted by the byte of the sand fly vector 
Lutzomyia longipalpis. Transmission of Leishmania by organ transplants or 
blood transfusions has also been documented.(Mestra et al., 2011; Dey and 
Singh, 2006; Antinori et al., 2008) 
Prior to the mid 1980’s, VL in Brazil was found as sporadic cases, 
mostly in rural areas, where the burden of Leishmania infection was less in 
humans and more in animal populations, such as foxes, dogs and 
rodents.(Badaro et al., 1983; Badaro et al., 1986; Evans et al., 1992) However, 
with increased urbanization the proportion of humans and dogs infected with 
Leishmania in densely populated areas has increased.(Marzochi et al., 1994; 
Lima et al., 2012; Costa et al., 1990; Jeronimo et al., 1994) VL has also 
reemerged in Europe, mostly with the HIV epidemic, (Villanueva et al., 2000; 
Alvar et al., 1996; Gramiccia et al., 2004) but also among immunocompetent 
people.(Millan et al., 2014; Calderaro et al., 2014; Ehehalt et al., 2014) 
Chagas Disease is caused by Trypanosoma cruzi, another 
Trypanosomatidae, and is endemic in 21 Latin American countries with over 6 
million people infected.(Otani et al., 2009; Coura, 1988; 1991; Mott et al., 
1990) Transmission of this pathogen to humans usually occurs by contact with 
feces of the reduvidae bugs when they take a blood meal. Infections through 
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blood and organ transplants have also been reported.(Coura and Borges-
Pereira, 2010) More recently in Brazil, outbreaks of acute Chagas were 
reported by oral infection, through the contamination of juices, such as açai 
and sugar cane.(Souza-Lima et al., 2013; Coura, 2006) 
The severity of Chagas Disease, and the risk of T. cruzi transmission 
through the blood supply, led to mandatory blood screening for T. cruzi in most 
Latin American countries beginning in the mid 1970’s. However, there is no 
serological assay to screen for L. infantum infections. Serological assays 
developed for either Leishmania or Trypanosoma genus have to estimate the 
potential for cross-reaction, since these pathogens share many common 
antigens.(Vega Benedetti et al., 2013; Sabino et al., 2010; Otani et al., 2009; 
Houghton et al., 2009) However, for blood screening purposes, there is a need 
for the test to be highly sensitivity (Kirchhoff et al., 2006; Otani et al., 2009) 
and, as result, false positive results occur, mostly in geographic areas where 
the two pathogens overlap. A radioimmune precipitation assay (RIPA) is the 
gold standard for the ascertainment of T. cruzi infection.(Shah et al., 2010) 
However, this assay is not available in Latin America.  
Because of the increased burden of asymptomatic Leishmania infection 
in urban areas of Brazil, there could be an increased risk of transmission of 
Leishmania through the blood supply.  Since in Brazil all blood units are tested 
for T. cruzi infection, we hypothesized that this risk is lower than expected, 
because the screening for T. cruzi would likely identify a proportion of 
Leishmania-contaminated blood. We determined the value of a commercially 
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available T. cruzi assay to identify Leishmania infection by testing samples of 
people with symptomatic visceral leishmaniasis (Symp VL), recovered visceral 
leishmaniasis (Rec VL) and healthy household contacts (HHC) of a VL case. 
We added the latter group, because they were at increased risk of Leishmania 
infection and at risk of developing VL for living .(Evans 1992, Jeronimo, 2004)  
METHODS 
Study Population  
A total of 573 subjects residing in the State of Rio Grande do Norte, 
Northeast Brazil, were studied. This area is endemic for both VL and Chagas 
Disease.(Jeronimo et al., 1994; da Camara et al., 2013) Of the samples 
screened, 350 were from Symp VL patients in which the diagnosis had been 
confirmed by clinical and parasitological findings, 87 were Rec VL subjects, 
who had also clinical and parasitological confirmation of disease, and 96 were 
their HHC. The last two groups were part of a cohort of people studied by our 
group.(Jeronimo et al., 2004; Jeronimo et al., 2007) 
T. cruzi ELISA 
Serum samples were screened for anti-T. cruzi antibodies using the 
Chagas III ELISA Test (BIOS, Chile). The test was carried out in an ELISA 
plate coated with whole extracts of T. cruzi epimastigotes. To each well, a total 
of 200-µl diluent provided by manufacturer was added, followed by 20 µl of sera. 
Plates were sealed and incubated for 1 hour at 37o C. We then followed the 
manufacturer’s protocol. The presence of antibodies was estimated using 
positive and negative sera provided by the manufacturer. Samples which OD 
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reading was 1 standard deviation above the cut off value was grouped as 
indeterminate and were not considered in the analysis.  
Leishmania ELISA  
Anti-Leishmania antibodies were detected by ELISA using a soluble 
Leishmania antigen (SLA), prepared from a local Leishmania isolate as 
previously described.(Braz et al., 2002)  Briefly, plates were coated with 500 
ng of SLA, blocked and incubated with diluted sera.  Anti-SLA antibodies were 
detected with a secondary anti-human IgG (Promega, Wisconsin, USA). 
Leishmania quantitative PCR 
Quantitative PCR was used to estimate the burden of Leishmania in the 
blood. Genomic DNA was extracted from leukocytes using a standard protocol  
(Grimberg et al., 1989) as previously described.(Macedo-Silva et al., 2014) All 
reactions were conducted on a 7500 Real Time PCR system from Applied 
Biosystems in a 10 μl reaction mixture, using the Mag1 chromosomal, and/or 
kDNA7 kinetoplast DNA primers and probes.(Weirather et al., 2011) A 
standard curve was generated from DNA extracted from a known number of 
cultured L. infantum promastigotes ranging from 106 to 10-3 promastigotes per 
well. The data were analyzed with SDS v1.3.1 software. 
Leishmanin skin test 
The delayed skin-test hypersensitivity response (Delayed Type 
Hypersensitivity) to Leishmania antigens was performed using 25 µg of 
Leishmania amazonensis proteins (Centro de Produção e Pesquisa de 
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Imunobiológicos, Secretaria de Saúde, Paraná, Brazil), which were injected 
intradermally. The size of induration was assessed after 48–72 hours and was 
measured in two perpendicular directions.(Sokal, 1975) An induration equal or 
greater than 5mm was considered positive.(Gouvea et al., 2007) 
Statistical analysis 
Chi-square likelihood ratio test was used to assess homogeneity of the 
distribution of categorical variables in independent groups. The McNemar´s 
test assessed the hypothesis that there was no association between the 
serological assays. Tables of frequency were constructed using two- and 
three-way analysis. A linear logistical regression model was used to evaluate 
the association between the tests and explanatory variables as groups 
(SympVL, RecVL and HHC), considering sex and age. The ANOVA test was 
used to compare the mean age between independent groups. 
Ethical considerations 
The protocol was reviewed and approved by the Universidade Federal 
do Rio Grande do Norte Ethical Committee (CEP-UFRN). The certificate of 
approval is 12675013.7.0000.5537.  All subjects provided written informed 
consent. 
RESULTS 
1. Assessment of serological assays for L. infantum and T. cruzi among 
people with confirmed VL (current or recovered) and their HHC 
The demographics of the groups are shown in Table 1. Of the 573 
people studied, 368 were males (64.2%) and the distribution of sex across the 
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three groups did not differ significantly p=0.202. The average age differed 
significantly among groups (p=0.002). The Rec VL were younger than the 
Symp VL and their HHC with a mean (±SD) age of 14.67±15.45 years. The 
recovered VL had mean 3.6± 3.3 years after treatment, varying in the range of 
0.2-13.0 years. 
 
Table 1. Sex and age distribution of the study population by group  
 Groups   
Variables Symp VL 
n = 388 
Rec VL 
n = 87 
HHC 
n = 98 
Total 
n = 573 
p 
Sex-Male n (%) 271 (69.8) 51 (58.6) 46 (46.9) 368 (64.2) 0.202(1) 
Age (mean±sd) 21.2±18.4 14.6±15.4 23.7±19.2 20.6±18.3 0.002(2) 
(1) Chi-Square = 18.791, 2 df  p=0.202 (2)ANOVA F Test F(2, 570)=6.086; p=0.002.   
Table 2 shows that 76% (n=266) of the Symp VL were positive in the T. 
cruzi assay, whereas 16.1% (n=14) and 8.3% (n=8), respectively, of the Rec 
VL and HHC were positive (p<0.0001). Thus, the sensitivity of T. cruzi assay 
in diagnosing SympVL was 76% and the specificity was 91.7%.  
 
Table 2. Results of the T. cruzi assay among people exposed to L. infantum with 
distinct clinical outcomes 
Results 
T. cruzi 
Groups  
Symp VL 
N (%) 
Rec VL 
N (%) 
HHC 
N (%) 
Total* 
N (%) 
Positive 266 (76.0) 14 (16.1) 8 (8.3) 288 (54.0) 
Negative 84 (24.0) 73 (83.9) 88 (91.7) 245 (46.0) 
Total 350 (100.0) 87 (100.0) 96 (100.0) 533 (100.0) 
Chi-Square Likelihood Ratio = 217.826, 2 df, p<0.0001. The results of the tests are 
heterogeneous among the phenotypes. * Samples which had indeterminate results were not 
considered, i.e., optic density close to the cut off value. 
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2. Analysis of Serological assays for Trypanosomatidae 
A total of 98.6% (n=345) of the Symp VL were positive in the SLA ELISA, 
whereas 81.6% (n=71) and 60.4% (n=58), respectively, of Rec VL and HHC 
were positive (Table 3).  The positive concordance between the two tests was 
greatest for the Symp VL group, with 74.9% of the 266 Symp VL positive in 
both methods, whereas the positive concordance for the Rec VL and their 
HHC were, respectively, 13.8% and 6.3%, p<0.0001.  
Figure 2 shows that there is a positive correlation of the two tests 
(Pearson correlation=0.487, p<0.0001, n=573) with an increase in the level of 
anti-leishmania antibodies, i.e, there is more concordance between the two 
tests the higher the anti-Leishmania antibodies. Symp VL (green dots) present 
the higher concordance, followed by recovered VL (blue dots). 
 
Table 3. Cross tabulation of the results of the T. cruzi and the SLA ELISA assays. 
Groups 
T. cruzi 
ELISA 
Assay 
Soluble Leishmania Antigens 
ELISA Assay 
Total n (%) Positive  n (%T) Negative n (%T) 
Symp VL Positive 262 74.9 4 1.1 266 76.0 
Negative 83 23.7 1 0.3 84 24.0 
Total 345 98.6 5 1.4 350 100.0 
Rec VL Positive 12 13.8 2 2.3 14 16.1 
Negative 59 67.8 14 16.1 73 83.9 
Total 71 81.6 16 18.4 87 100 
HHC Positive 6 6.3 2 2.1 8 8.3 
Negative 52 54.2 36 37.5 88 91.7 
Total 58 60.4 38 39.6 96 100.0 
McNemar Test p<0.0001.Graycells show discordance between the two tests. 
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Figure 2.  Results of the log of the(SLA ELISA/Cutoff) (X axis) versus the log 
of the(T. Cruzi/Cutoff)assay (Y axis). Values greater than 0 indicate that the 
assay is positive.  
Relative values were used because of variation in the cut off value. Green dots= Symp VL; 
blue dots =Rec VL and black dots=HHC. 
 
There was no difference in the positivity of the SLA-ELISA when 
considering gender (p=0.202), but there was a difference in the T. cruzi 
ELISA, with more males positive (p<0.0001) (Table 4). Using a logistic 
regression model and taking into account gender and the three groups, i.e, 
Symp VL, RecVL and HHC, it was observed that the risk of ascertaining the 
status as Symp VL was 32.8 times greater when the T. cruzi ELISA was 
positive (p<0.001) (Table 5).  
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Table 4. Results of  serological assays for T. cruzi and L. infantum by sex 
Serological ELISA 
Assay Results 
Sex  
Total  
N (%) 
Male 
N (%) 
Female 
N (%) 
Soluble Leishmania 
Antigens (SLA) 
Positive 334 90.8 179 87.3 513 89.5 
 Negative 34 9.2 26 12.7 60 10.5 
 Total 368 100.0 205 100.0 573 100.0 
T. cruzi         
 Positive 204 60.0 84 43.5 288 533 
 Negative 136 40.0 109 56.5 245 46.0 
 Total 340 100.0 193 100.0 54.0 100.0 
 SLA, (Chi-Square = 1.627,  1 df  p=0.202); T.cruzi, (Chi-Square = 13.467,  1 df  p<0.0001) 
 
 
Table 5.  Regression model considering the results of the two serological 
tests (SLA and T. cruzi) and groups. 
Covariate p 
Odds 
Ratio 
Exp(β) 
95% Confidence Interval 
Lower Bound Upper Bound 
Symp VL/HHC <0.001 32.8 15.2 70.6 
Rec VL/HHC 0.134 2.0 0.8 5.1 
Sex (Male) 0.089 1.4 0.9 2.3 
Model: log  	
 = β + βRecovered VL + βsymptomatic VL + βMale + error 
 
Table 6 shows the logistic regression model, which took into account the 
log of the odds of the serological assays (SLA and T. cruzi, respectively) and 
as explanatory variables, the phenotype (Symp VL, Rec VL or HHC) and age 
(years). For the T. cruzi assay the positivity was higher for Symp VL (OR 39.1, 
CI 17.9-85.5, p<0.001) than for Rec VL (OR 2.2; p=0.053). The positivity of the 
assays increased with each additional year of the subject’s age (p=0.006). 
Similar results were observed in the SLA assay, but with a decrease in the 
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positivity with age (OR=0.977; p=0.004). The odds ratio of SLA for Symp VL 
was 41.5 (CI 16.6-103.6).  
 
 
 
Table 6.  Parameter estimates of logistical models with the serological assay results 
as response and group status and age as predictors 
 
Assay Source S.E. p 
Odds 
Ratio 
Exp(β) 
95% Confidence Interval 
Lower Upper 
T. cruzi Symp VL/HHC 0.40 <0.001 39.14 17.91 85.51 
 Rec VL/HHC 0.48 0.053 2.53 0.99 6.48 
Age (Years) 0.01 0.006 1.02 1.01 1.03 
SLA Symp VL/HHC 0.47 <0.001 41.55 16.65 103.65 
 Rec VL/HHC 0.36 0.016 2.35 1.17 4.71 
Age (Years) 0.01 0.004 0.98 0.96 0.99 
Model:   	
 =  + Recovered + Symptomatic VL + Age + error Household contact is the reference. 
 
3. Anti-Leishmania antibodies and DTH responses 
The mean (±SD) concentration of anti-leishmania antibodies 
[log(SLA/Cutoff)]for Symp VL, Rec VL and HHC were1.39 ± 0.83, 0.75 ± 1.11 
and 0.02 ± 1.05, respectively. The DTH response was significantly different 
among the groups, with a greater response among the Rec VL (66.2%) than 
HHC (50.8%) or Symp VL (0.8%), (p<0.0001). As expected, the quantity of 
Leishmania DNA was higher in the Symp VL (Table 8). 
Table 7 – Distribution of DTH response among groups 
Results Symp VL n (%) Rec VL n (%) HHC n (%) Total n (%) 
Positive 1 (0.8) 45 (66.2) 30 (50.8) 76 (29.7) 
Negative 128 (99.2) 23 (33.8) 29 (49.2) 180 (70.3) 
Total 129 (100.0) 68 (100.0) 59 (100.0) 256 (100.0) 
Chi-Square Likelihood Ratio = 130.88, 2 df, p<0.0001.  
  
 
16
 
 
Table 8. Quantification of Leishmania DNA in  the blood 
Groups 
PARASITEMIA  
Mean ± SEM 
kDNA-7 
(parasite∕80ng DNA)  
MAG-1 
(parasite∕80ng DNA) 
Symp VL 329.8 ± 122.7 212.1 ± 88.5 
Rec  VL 48 ± 0.24  38 ± 18.0 
HHC 13.1 ± 9.5 6.0 ± 5.8  
SEM: Standard error of mean 
 
DISCUSSION 
Several studies have addressed the issue of cross reactivity between 
serological assays for Leishmania and T. cruzi.(Carvalho et al., 1987; Sabino 
et al., 2010; Otani et al., 2009). Caballero et. al. reviewed five commercially 
available ELISAs for T. cruzi, and Leishmania spp were the most common 
pathogens to cross react.(Caballero et al., 2007) In this work, we used one of 
the assays tested by Caballero (Chagas III) and examined individuals living in 
a region endemic for both Chagas disease and VL who were either Symp VL, 
Rec VL or exposed HHC. The T. cruzi ELISA assay was very sensitive in 
detecting Leishmania infection, but its concordance was greater with an 
increasing level of anti-Leishmania antibodies.   
Although there have been available assays for the diagnosis of 
VL,(Matlashewski et al., 2013; Khanal et al., 2010; Chappuis et al., 2006; Braz 
et al., 2002) there is no gold standard.  Parasitological confirmation by bone 
marrow or spleen aspirations is still widely used in most endemic countries to 
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confirm VL. In addition, in Latin America VL used to be a rural disease with 
sporadic cases presenting with prominent cachexia and high mortality (Badaró 
1986, Evans et al, 1992).  VL has emerged now as a disease of urban areas, 
(Costa et al., 1990; Jeronimo et al., 1994; Marzochi et al., 1994; Silva et al., 
2001), concomitant with transmission to previously non-endemic areas in the 
south of Brazil and north of Argentina. (Salomon et al., 2008) Thus, there is a 
large population of potential Latin American blood donors who are at risk of 
Leishmania infection. But, based on previous studies (Caballero et al., 2007; 
Sabino et al., 2010) and the universal screening for T. cruzi in Brazil and other 
Latin American countries, we hypothesized that the risk of Leishmania 
transmission could actually be lower than expected since the T. cruzi ELISA 
assay could detect some of the Leishmania-contaminated blood. We observed 
that the T. cruzi ELISA assay had a sensitivity of 76% and specificity of 91.7% 
for identifying symptomatic VL, but the sensitivity was lower with lower levels 
of anti-Leishmania antibodies.  
RIPA is the confirmatory test used in the United States for T. cruzi 
infection.(Shah et al., 2010) However, this assay is not available in Latin 
America, where there is a great need of a very specific assay if the first ELISA 
screening is positive. Recombinant proteins are being tested and might be an 
easier assay than immunofluorescence (Caballero et al., 2007) or RIPA,(Shah 
et al., 2010). There is high cross reactivity in secondary immunofluorescent 
assays, and no availability of RIPA in most endemic area and recombinant 
antigens might be an option.(Duthie et al, manuscript in preparation) 
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Although this study was not primarily an epidemiological one, we 
observed there was no gender difference in the level of antibodies detected by 
SLA ELISA, but for T. cruzi. The discordance for gender results could be due 
to the type of antibodies in accordance to disease status. In addition, there 
was an age difference between the two assays, that might be because the 
SympVL people were on average older than the Rec VL. Indeed, we have 
seen an increase in the age of VL in Brazil.(Nascimento et al, 2010)  As we 
have previously reported, Leishmania infection tends to occur in the vicinity of 
the household, and Leishmania transmission by the sandfly vector is usually 
after sunset, when most families are at home with potentially equal 
exposure.(Jeronimo et al., 2004; Macedo-Silva et al., 2014) 
The discordance between the two assays was greater for the Rec VL 
and HHC. A potential explanation for this discordance could be the IgG isotype 
switch from IgG1 to IgG2 that occurs after cure or self-resolution of 
Leishmania infection.(Bhattacharyya et al., 2014) We also have previously 
observed that during recovery from VL, there is an inverse correlation between 
the level of antibodies and the DTH response to Leishmania.(Miles et al., 
2005), which reflects the switch in IgG type and development of a protective 
Th1 response.  
Both qPCR assays were able to detect Leishmania DNA in the blood of 
all three groups studied. These two assays are very specific for L. infantum 
infection.(Weirather et al., 2011) However, the results of the tests depend on 
the quantity of DNA. The sensitivity of any molecular method technique to 
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diagnosis a pathogen improves with the amount of DNA.(Loonen et al., 2013) 
We had the limitation that most samples tested for culture or DNA were 
extracted from a small volume of blood (4-7 ml) and from a single blood draw. 
Therefore, we might have missed identifying parasites. However, quantitative 
PCR, if standardized, would be a more sensitive and specific assay, and 
easier to implement in most endemic areas, than culture. 
CONCLUSIONS 
The commercial T. cruzi assay (CHAGAS III) is sensitive for detecting L. 
infantum infection. The positivity of the test correlated with the level of anti-
Leishmania antibodies. Similarly, the SLA ELISA assay could also detect 
occult T. cruzi infection. These findings indicate the need for better assays to 
rule out dual infection and to ascertain the correct diagnosis of either L. 
infantum or T. cruzi infections. Standardized qPCR might be an option that 
could be implemented to distinguish infection by either pathogen.  
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CHAPTER 2 
 
Serological Survey of Leishmania Infection in Blood Donors from an Endemic 
Area of Visceral Leishmaniasis in Brazil   
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ABSTRACT 
MANUSCRIPT 2: Serological survey of Leishmania infection in blood donors 
from an endemic area of visceral leishmaniasis in Brazil 
BACKGROUND. Asymptomatic Leishmania infection has increased in urban 
areas of Brazil, which pose a risk of Leishmania transmission through blood or 
organ transplant. 
OBJECTIVES: to determine the prevalence of Leishmania infantum and 
Trypanosoma cruzi infections in blood donors of an endemic area for visceral 
leishmaniasis in Brazil. 
METHODS. A cross sectional study was performed, with weekly recruitment, 
of volunteers, from February 2014 to January 2015. A total of 1556 
participants who were donating blood in Natal, Brazil, were recruited. 
Participants answered a questionnaire related to exposure to Leishmania. 
Results of their blood screening were analyzed. Blood samples were tested for 
Leishmania infection using a soluble Leishmania antigens (SLA) ELISA assay. 
Descriptive statistics and graphs were used to describe distribution of 
continuous variables. Likelihood Ratio Chi-Square test evaluated the 
association between categorical variables. Simple and multiple regression 
models to evaluate the effect of covariates and factors on Leishmania 
response. The results of the SLA ELISA were log transformed.  
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RESULTS: A total of 51,463 people donated blood to public blood banks in 
2014 and of these, 1554 (3%) were recruited into the study over a 12-month 
period. The majority of donors were males (82.4%) and married (51.8%). The 
mean (± sd) age of the participants was 35.6 ± 9.9, ranging between 16.1 to 
69.6 years. The literacy rate was high with 68% of the participants had 
completed high school. The mean (± standard deviation) body mass index for 
males and females were, respectively, 27.92 ± 3.96 and 27.99 ± 4.38. The 
prevalence of T. cruzi and Leishmania were 0.19% and 2.5 %. Leishmania 
was isolated from one of the samples cultured (600). 
CONCLUSIONS. There is risk of Leishmania transmission through the blood 
supply. It is warranted close monitoring of blood recipients in VL endemic 
areas, principally in those with some type of immunosuppression. T. cruzi 
ELISA assay can identify a subgroup of L. infantum contaminated blood, but 
does not exclude all Leishmania positive samples. 
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INTRODUCTION 
Leishmania infantum is the major etiological agent for visceral 
leishmaniasis (VL) in Latin America and Europe. (Garnham, 1971; Belo et al., 
2014)  Changes in in the epidemiology of VL have occurred in the last 30 
years with migratory movements, environmental changes, urbanization, global 
warming and HIV pandemic. (Daher et al., 2009; Desjeux, 2001a; Mott et al., 
1990; Alvar and Jimenez, 1994; Nascimento et al., 2011; Fernandez-Guerrero 
et al., 1987) In Brazil, L. infantum is transmitted to vertebrates through the bite 
of female Lutzomyia longipalpis. Dogs are presumed to be the main reservoir 
of Leishmania, but the role of humans as reservoir has not been carefully 
considered in Europe or Latin America.(Ready, 2008; Deane, 1961) 
Attempts to control human and canine VL have been aimed to culling of 
dogs, after the recognition of human disease, in a particular neighborhood. 
However, this has not proved to be effective in Brazil.(Courtenay et al., 2002; 
Costa et al., 2013; Nunes et al., 2008). Control measures are only launched 
when there are reports of human VL. Furthermore, there is a large variation in 
Leishmania incubation period in humans, i.e., from infection to disease, 
varying from several months to years after infection, (Badaro et al., 1986a; 
Evans et al., 1992; Jeronimo et al., 2000).  Therefore, the epidemiological 
milieu at the time that controls measures are implemented may differ from the 
time when Leishmania infection occurred. Moreover, the removal of infected 
dogs is sporadic and the burden of asymptomatic infections in either dogs or 
humans has not been taken into account. 
  
 
31
Transmission of leishmania is usually thought to occur through the 
female sand fly vectors. However, vertical transmission in dogs, in the United 
States, (Boggiatto et al., 2011), and cases reports in humans, raises 
awareness about other routes of infection. There is an increased risk of 
Leishmania infection in household contact of a VL case (Evans et al, 1992). 
Infection through needle sharing was also a mode of Leishmania transmission 
in Spain, India and Latin America (Mestra et al., 2011; Dey and Singh, 2006; 
Le et al., 1999). In Europe, VL reemerged in HIV-infected/injection drug users 
who shared needles.(Alvar et al., 1989; Villanueva et al., 2000; Desjeux et al., 
2001) These observations reinforce the need to better estimate alternative 
means of Leishmania transmission.  
VL in Brazil used to be a disease of poverty and cases were sporadic 
occurring in rural areas of Northeast Brazil. (Deane, 1958) The risk factors for 
disease development included malnutrition, coinfections and 
immunosuppressive disorders. (Badaro et al., 1986c; Cerf et al., 1987; 
Desjeux, 2001b) The ratio of Leishmania infection to VL development was 
high then, (Badaro et al., 1986b), but lower in endemic areas in Europe. (Moral 
et al., 2002) Nevertheless, in Brazil, with improvement in public health care 
and in the economy that occurred in mid-1990’s, decreased some of these risk 
factors for VL. (Maciel et al., 2008; Andrade et al., 2009; Lima et al., 1992; 
Lima Maciel et al., 2014)  
Although asymptomatic L. infantum infection has increased in Brazil, with 
autochthonous of VL in all geographic regions of the country (Lima et al., 
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2012; Gouvea et al., 2007) there has not been an increase in the incidence of 
symptomatic VL. (Maia-Elkhoury et al., 2008) In a preliminary study conducted 
in Natal,(Monteiro et al, 2015, submitted), we showed presence of viable 
Leishmania in blood collected from apparently health donors. Those samples 
had been discarded because of positivity for T. cruzi or because of insufficient  
volume. This finding led us to perform a serological survey of L. infantum to 
estimate the prevalence of infection by this pathogen in an endemic area for 
VL in Brazil. We also aimed to determine whether there was seasonality in 
Leishmania infection rate.  
 
METHODS 
Study Design and population 
A cross sectional study was performed to estimate the prevalence of 
occult Leishmania infection in blood donors from Natal, state of Rio Grande do 
Norte, Brazil, an area endemic for VL.(Jeronimo et al., 1994; Jeronimo et al., 
2004) Participants who were blood donors from the two main public blood 
banks in Natal were asked to participate into this study. The sample size was 
calculated based on prevalence of asymptomatic L. infantum infection as 
varying from 5-20%, 95% CI. However, as the prevalence in January 2014, 
was lower than estimated, we recalculated the sample based on a prevalence 
of 2%. A total of 1546 people were recruited over a 12 month period, from 
February 2014 through January 2015, with a mean weekly recruitment of 30 
participants. We had permission of the donors to obtain the results of their 
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laboratory tests performed as part of the blood screening. People with 
hematocrit less than 40 or history of surgery in the past 12 months were 
excluded from donation. Participants were recruited into our study after being 
interviewed by the blood bank staff and after having had the hematocrit 
determined. Samples were collected at the end of their blood donation. Blood 
was collected in vacutainer tubes (Becton Dickinson) containing EDTA as 
anticoagulant (2 tubes) and no anticoagulant (1 tube).  
Blood screening panel used in Natal, Blood bank.  
All blood collected in Brazilian blood banks are screened by ELISA for 
anti-HIV, anti-HCV, anti-HBc, anti-HTLV1 and anti-T. cruzi. VDRL was 
determined by the flocculation method. In October 2014, molecular methods 
started to be implemented (NAT-HCV and NAT-HIV by PCR). However, we 
only used the serological results, since samples recruited in the first 8 months 
of the study were not screened using molecular methods. Natal is not endemic 
for malaria, so malaria screening is not in place in the blood bank. People with 
recent history of travelling to endemic areas for malaria in Brazil are usually 
excluded from donation. 
Screening for Leishmania infection 
Leishmania culture and speciation  
Buffy coats were prepared from 4 ml of fresh blood by centrifugation at 
1000 x g for 15 min. Twenty μl of buffy coat overlying erythrocytes was 
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inoculated into each of two tubes containing NNN blood agar or Schneider’s 
medium. Capped tubes were cultured at 26°C, and samples were examined 
for growth every 3 days for up to 6 weeks. Leishmania isolates were typed by 
PCR, genotyping for ITS (Kuhls et al., 2005), following revised 
protocol.(Macedo-Silva et al., 2014) 
Leishmania quantitative PCR 
Quantitative PCR was used to estimate the Leishmania loads. Total 
DNA was extracted from 4-6 ml ml of blood.(Grimberg et al., 1989) All 
reactions were conducted on a 7500 Real Time PCR system from Applied 
Biosystems in a 10 μl reaction mixture, using Mag1 chromosomal, and kDNA7 
kinetoplast DNA primers and probes.(Weirather et al., 2011) A standard curve 
was generated from DNA extracted from a known number of cultured L. 
infantum promastigotas, local isolate, ranging from 106 to 10-3 promastigotes 
per well.  The cycle threshold (Cts) was analyzed with SDS v1.3.1 software, 
with the threshold for fluorescence detection set manually at 0.2 for all 
reactions. 
ELISA to detect anti-Leishmania antibodies 
Anti-Leishmania antibodies were detected by ELISA using a soluble 
Leishmania antigen (SLA), a soluble lysate of promastigotes prepared from a 
local Leishmania isolate as previously described.(Braz et al., 2002)  Briefly, 
plates were coated with 500 ng of SLA. They were blocked and incubated with 
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diluted blood.  Anti-Leishmania antibodies were detected with a secondary 
anti-human IgG (Promega, Wisconsin, USA).  
Rainfall data 
The 3-year time series of rainfall data was obtained from the State of Rio 
Grande do Norte Agriculture Secretariat. The station is located in Natal, 
latitude -5.91 and longitude -35.2. 
Statistical Analysis 
Descriptive statistics and graphs were used to describe distribution of 
continuous variables. ANOVA and t-student tests were used to compare the 
means among independent groups. Two by two tables and the Likelihood 
Ratio Chi-Square test evaluated the association between categorical 
variables. Simple and multiple regression models evaluated the association of 
covariates and SLA response. The results of the SLA ELISA were log 
transformed and the cutoff value for each plate was considered. Microsoft 
Excel and SPSS  (www.spss.com) were used for data analysis. 
Ethical considerations.  
The protocol was reviewed and approved by the Universidade Federal do Rio 
Grande do Norte Ethical Committee (CEP-UFRN, certificate of approval 
No12675013.7.0000.5537). All participants signed both the blood bank and our 
research consent form.   
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RESULTS 
1. Characteristics of the blood donors 
A total of 51,463 blood samples were screened in public blood banks of 
the state of Rio Grande do Norte, Brazil, between January 2014 to January 
2015.  Of those, 1544 (3%) were recruited into our studies and the majority of 
were males (82.4%) and married (51.8%). Of those, 45.1% had completed 
high school and 23% had a college degree or were college students, and only 
0.3% were illiterate. They earned (82.4%)  less than 3 Brazilian monthly 
minimal wages (approximate U$800), and 98.8%resided in the state of Rio 
Grande do Norte and had lived in the same municipality for over 5 years 
(87.5%). The majority (77%) had donated blood more than once. There was 
no difference in the BMI between male and females (p>0.05), but only 24.8% 
of the population had normal BMI, Figure 1. BMI increased with the age (Table 
1), as expected. 
 
Table 1. Statistics for BMI by age groups 
Age Group 
N Mean 
Std. 
Deviation 
95% Confidence 
Interval for 
Mean 
Minimum Maximum 
Lower 
Bound 
Upper 
Bound 
<= 28 years 360 27.11 4.02 26.69 27.52 18.93 48.45 
28 --| 34 years 355 27.81 4.14 27.38 28.25 17.72 40.04 
34 --| 42 years 395 28.19 3.80 27.81 28.56 19.93 42.94 
> 42 years 385 28.57 4.06 28.17 28.98 18.42 46.61 
Total 1495 27.94 4.04 27.73 28.14 17.72 48.45 
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Figure 1. Distribution of the body mass index by category (A) and age group 
(B). 
 
 
2. Results of the blood bank screening 
The results of the blood screening assays for the entire overall 
population who donated blood in the state of Rio Grande do Norte and our 
sample populations are shown in Table 2. For any positive pathogen results, a 
second blood sample was requested, by the blood bank, and confirmatory 
assays were performed. We had no access to the second sample or to the 
confirmatory test results. Anti-HBc was the most prevalent positive serology in 
A       B 
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both the general blood donor population (82.7 per 10,000) and our study 
sample (90.8 per 10,000, 95%CI[43.4; 138.1]), Table 2.; whereas anti-T. cruzi 
was 15.3/10,000 for the general population and 19.5 per 10,000 people in our 
sampling, 95%CI[0.0; 41.4]. 
 
Table 2. Results of the blood screening. The ratio infection rate is presented per 10,000 
with the 95% confidence interval.   
ScreeningTests 
Population Sample 
95% 
Confidence 
Interval(2) 
Positive N 
per(1) 
10000 
Positive n 
per 
10000 
Lower Upper 
Anti-HbC 426 51463 82.7 14 1542 90.8 43.4 138.1 
VDRL 206 51463 40.0 4 1541 26.0 0.6 51.4 
Anti HIV I/II (REC) 88 51463 17.1 3 1541 19.5 0.0 41.5 
Anti T. cruzi 79 51463 15.3 3 1542 19.5 0.0 41.4 
Anti HTLV I/II 69 51463 13.4 1 1542 6.5 0.0 19.2 
Anti HCV 68 51463 13.2 2 1542 13.0 0.0 30.9 
Anti HIV I/II ( PS) 66 51463 12.8 0 1542 0.0 0.0 0.0 
HbsAg 63 51463 12.2 5 1542 32.4 4.0 60.8 
(1) Note that these values are within the 95% CI.   (2) 95% CI for sample prevalence by 10,000. 
 
3. Prevalence of Leishmania infection in blood donors from Natal,Brazil 
The prevalence of Leishmania infection estimated by SLA ELISA was 
2.5%, with 2.7% in males and in1.5% in females (χ2(1)= 1.674; p=0.196), 
Table 3. The quantitative results of the anti-leishmania antibodies, either 
positive or negative, are shown in Figure 2. Of those who were positive, the 
mean estimate of Leishmania by kDNA was 8.5 parasites/80 ng of total DNA 
(±7.5). 
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Table 3. Results of the anti-leishmania antibodies in blood donors 
SLA ELISA 
Sex Total 
n (%) Male n(%) Female n (%) 
Negative 1238 97.3 267 98.5 1505 97.5 
Positive 35 2.7 4 1.5 39 2.5 
Total 1273 100.0 271 100.0 1544 100.0 
χ2(1)= 1.674; p=0.196 
 
We log transformed the results of the SLA ELISA, after dividing its 
absorbance by the cut off value of the test. Figure 3 shows the distribution of 
the logSLA ratio, a value greater than 0 indicates that the test was positive. 
There was no difference in infection rate between sex  (p=0.963). 
 
Figure 2. Quantitative results of the SLA ELISA, stratified by positive positive 
and negative values. 
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Figure 3.  Frequency Distribution of LogSLARatio 
 
The concordance of SLA and T. cruzi was high, with 97.3% (1500) 
negative for both assays (Table 4). The prevalence of T. cruzi was 0.19% 
(3/1542). One sample was both T. cruzi and SLA positive. Of the samples 
cultured (n=600), one was positive and the pathogen isolated was typed as L. 
infantum. This blood  sample was also positive for anti-Leishmania antibody. 
Table 4. Cross tabulation of SLA ELISA with T. cruzi ELISA 
Anti T. 
cruzi 
SLA Total  
N (%) Positive  
N (%) 
Negative 
N (%) 
Negative 39 (2.5) 1500 (97.3) 1539 (99.8) 
Positive 1 (0.1) 2 (0.1) 3 (0.2) 
Total 40 (2.6) 1502 (97.4) 1542 (100.0) 
McNamar Test, p<0.0001 
 
3. Seasonal variation of Leishmania infection 
Figure 3A shows the quarterly rainfall in Rio Grande do Norte, and Figure 
3B shows the LogSLA ratio with the 95% confidence interval for the 
Leishmania seroprevalence by quarter over the span of a year. There is a 
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noticeable intra-annual variation, with an increase in Leishmania seropositivity 
between the months of April-September (quarters 2 and 3). We used a linear 
model considering the LogSLA ratio as the response and the quarters as 
predictor. A significant variation of LogSLA ratio was observed depending on 
quarter (F(3, 1549) =14.1, p<0.001) with increased prevalence of Leishmania 
infection between April-June (β=0.299; p<0.0001) and for July-September 
when October-December was used as reference, Table 5. 
 
Table 5. Parameter estimates of Leishmania infection along the year, using a 
linear model  considering the Log SLA ratio as the Dependent Variable 
Parameter B 
Std. 
Error 
t Sig. 
95% Confidence Interval 
Lower 
Bound 
Upper  
Bound 
Intercept -1.291 .030 -43.278 <0.0001 -1.350 -1.233 
[Quarter=1] 0.083 .044 1.881 0.0600 -0.004 0.170 
[Quarter=2] 0.409 .039 10.387 <0.0001 0.332 0.486 
[Quarter=3] 0.299 .041 7.372 <0.0001 0.220 0.379 
[Quarter=4] reference . . . . . 
 
A                                                                                             B. 
Figure 4 – Rainfall per quarter for the state of Rio Grande between January 2012 to 
February 2015 (A) and the Log of the SLA/Ratio, between December 2013 to January 2015, 
with 95% confidence interval (B). 
  
 
42
 
The temporal relation of rainfall index with Leishmania seropositivity 
detected over calendar year 2014 is shown in Figure 4. There is a lag between 
detection of Leishmania infection and the increase in rainfall. 
 
 
Figure 5. Temporal variation in rainfall from January 2012 to February 2015 
and the LogSLARatio from December2013  to January 2015. 
 
 
4. Risk factors for Leishmania infection 
Several putative risk factors for Leishmania infection, including history 
of VL in the family, presence of dogs in the house or in neighborhood, history 
of Chagas disease in the family, presence of dogs, but they were not 
associated with Leishmania seropositivity. The only factor associated was 
history of travel outside of their municipality with an odds ratio of a positive 
SLA of 2.2 (P = 0.021) (Table 6).   
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Table 6. Logistic Regression Models of Potential risk factors for leishmania infection 
 
Risk/n of response SLA Significance 
 Positive n 
(%) 
Negative 
n (%) 
OR SE p 
History of travel (n=1537) 25 (65.8) 696 (46.4) 2.22 0.035 0.021 
History of VL  in the family 
(n=1548) 
- 19 (1.3) - 
- 0.998 
History of Chagas disease 
in the family (n=1534) 
1 (2.6) 42 (2.8) 0.94 1.03 0.948 
Presence of dogs in the 
household (n=1548) 
20 (52.6) 688 (44.7) 1.37 0.33 0.334 
Presence of dogs in the 
neighborhood (n=1530) 
27 (71.1) 
989 (66.3) 
1.25 0.36 0.540 
Resided in the same house 
Chagas Case (n=1042) 
- 
26 (2.6) 
- - 0.998 
Reduvidae bug in the 
residence (n=1133) 
2 (5.6) 
60 (5.5) 
1.02 0.74 0.982 
Alcohol intake (n=1529) 8 (21.1) 526 (35.3) 0.49 0.40 0.075 
 
 
 
DISCUSSION 
The safety of the blood supply is a challenge everywhere. This task 
becomes more complex, with the emergence or re-emergence of pathogens, 
which warrant a need for setting up new techniques for blood 
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screening.(Salunkhe et al., 2015; Leparc, 2015) Introduction of molecular 
techniques to ascertain presence of pathogen, in addition to antibody 
responses, has been an important improvement in safety.(Leparc, 2015) 
Policies regarding the exclusion of certain groups as a result of the HIV 
pandemic have been questioned.(Brailsford et al., 2015) However, the ease of 
travelling and migratory movements nowadays, with changes in what used to 
be traditional endemic areas, signal the need of continuous surveillance and 
implementation of new screening methods for blood products. We aimed to 
estimate the burden of Leishmania infection in blood donors residing in an 
endemic area for VL in Brazil.(Mott et al., 1990; Gratz, 1999; Nascimento et 
al., 2008) We found that the prevalence of Leishmania infection was 2.5% 
based on the antibody response, with one sample blood sample of 600 tested 
that had viable Leishmania confirmed by growth of leishmania in culture.   
Malnutrition used to be an important health problem in Brazil, increasing 
the risk of developing symptomatic infectious diseases, (Badaro et al., 1986c; 
Harrison et al., 1986; Cerf et al., 1987; Lima et al., 1992). Several studies 
show the association of malnutrition with development of VL.(Harrison et al., 
1986; Cerf et al., 1987) However, more recently Brazil has gone through a 
transitional phase in which obesity has become a public health issue (Strufaldi 
et al., 2008; Hallal and Irwin, Jr., 2012), and the burden is greater in people 
from a lower socioeconomic stratum.(Lyra et al., 2012) Our data reflects this 
transition in nutrition status, in which 75% of our study participants were in the 
group of overweight (46.8%) or obesity 1 (23.0%) or Obesity 2 (4.4%). 
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The majority of our donors were males, reflecting the overall pattern of 
blood donation in Brazil, where males more often donate blood. About one 
third of donors came to the blood bank to help a friend or a relative who 
needed blood. This is a common practice in Brazil, but there is also 
encouragement from the health sector for this practice, aiming to keep an 
adequate blood supply level. There is no compensation for blood donation in 
Brazil. This policy was started in early 1970’s to decrease the likelihood of 
underprivileged people donating blood multiple times because of the 
compensation. (Andrade et al., 2009) 
The overall prevalence of T. cruzi infection in the donors was 0.15%, 
with 40% of the cases positive from the Natal area. Half of those positive 
cases were low-reactive (data not shown). Low levels of antibodies are a 
common finding in many endemic areas for Chagas disease and the 
significance of this is not entirely understood.(Remesar et al., 2009; Remesar 
et al., 2015). This could reflect either decrease in the burden of infection or an 
evolving one. In either situation, close follow-up is needed. About half of the 
samples that tested positive for Chagas came from the Natal area, which is 
not endemic for Chagas, but for L. infantum.(Jeronimo et al., 2004; Lima et al., 
2012) However, since there has been migration from the rural areas endemic 
for Chagas disease to Natal, we could not exclude that some of these positive 
samples would have dual infection. Natal area is highly endemic for VL and in 
focal areas where there has been either human or canine VL the rate of 
asymptomatic infection can be as high as 40%. (Jeronimo et al, 2004; Lima et 
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al, 2012) At any rate, there is a need of a better confirmatory assay for both L. 
infantum and T. cruzi. Careful monitoring of cardiac function is warranted. 
Ribeiro et al, found electrocardiographic (ECG) abnormalities more frequently 
in T. cruzi seropositive than in seronegative blood donors. The ECG 
abnormalities could help the recognition of seropositive cases, who warrant 
long-term careful follow-up.(Nascimento et al., 2012; Ribeiro et al., 2013) 
We first determined the sample size with an estimate based on a 
previous study around Natal. (Lima et al, 2012). However, because of the low 
detection rate observed in the first two months of the study, we increased the 
sample size. This shows the importance of close monitoring of cross-sectional 
studies of vector-born diseases.  
Leishmania transmission depends on vector density, which is 
influenced by environmental factors. Several studies have addressed the 
seasonality of VL, but there is not to our knowledge studies showing the 
seasonality of infection with Leishmania infantum. Leishmania infection tends 
to occur in focal areas, and the presence of canine leishmaniasis influences 
the level of infection in humans.  
We collected blood samples, weekly, aiming to identify any potential 
variability in infection along the year. Studies on El Niño have shown 
implications in diseases such as malaria, (Gagnon et al., 2002), and 
leishmaniasis (Chaves et al., 2014; Franke et al., 2002). We observed a 
discrete lag between detection of Leishmania infection and increase in rainfall. 
However, we had only monitored for 12 months, not long enough to confirm 
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this trend. More observations are needed, with surveillance of greater than a 5 
year cycle, to accurately determine the pattern of Leishmania transmission. 
Finally, the fact that we successfully cultured Leishmania from one blood 
donor, and having obtained it from a small sample of blood, confirms that there 
is a true risk of Leishmania transmission through the blood supply.  
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